salmeterol xinafoate has been researched along with Tricuspid Incompetence in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bosotti, L; Carlucci, P; Cazzola, M; Centanni, S; Mantero, A; Mondoni, M; Santus, P | 1 |
1 trial(s) available for salmeterol xinafoate and Tricuspid Incompetence
Article | Year |
---|---|
Doppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patients.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Albuterol; Blood Pressure; Double-Blind Method; Echocardiography, Doppler; Ethanolamines; Forced Expiratory Volume; Formoterol Fumarate; Heart Rate; Humans; Middle Aged; Pilot Projects; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Treatment Outcome; Tricuspid Valve Insufficiency | 2007 |